T0	Outcomes 243 251	efficacy
T1	Outcomes 256 262	safety
T2	Outcomes 319 336	survival analyses
T3	Outcomes 349 355	safety
T4	Outcomes 666 684	antitumor activity
T5	Outcomes 689 696	safety.
T6	Outcomes 783 791	survival
T7	Outcomes 1032 1041	median OS
T8	Outcomes 1156 1158	OS
T9	Outcomes 1250 1308	Grade 3 or 4 fatigue, neutropenia, and febrile neutropenia